11 March 2025
One Health Group
plc
("One
Health" or the "Company")
Director
Dealing
One
Health Group plc (AQSE: OHGR), a provider of NHS-funded medical
procedures, announces that further to the details set out in the
circular to shareholders dated 20 February 2025, Derek Bickerstaff,
Non-Executive Chairman of One Health, has notified the Company that
he has transferred 1,100,000 ordinary shares of 0.5 pence each in
the Company ("Ordinary
Shares") to his wife and person closely associated, Michelle
Bickerstaff.
Additionally, Shantanu Shahane, Chief Medical Officer of One
Health, has notified the Company that he has transferred 35,000
Ordinary Shares to his wife and person closely associated, Angela
Shahane.
Following the above transactions, the number
and beneficial ownership of Ordinary Shares held
by Mr Bickerstaff and Mr Shahane and persons closely related are unchanged.
For
more information, please contact:
|
One
Health Group plc
Derek Bickerstaff,
Chairman
Adam Binns, CEO
|
via
Square1 Consulting
|
|
Panmure Liberum (Corporate Adviser, Nominated Adviser and Sole
Bookrunner)
Emma Earl, Will Goode, Mark Rogers,
Joshua Borlant
Rupert Dearden
|
Tel: +44
(0) 20 3100 2000
|
|
Square1 Consulting
David
Bick
|
Tel: +44
207 929 5599
+44 7831
381201
|
|
|
|
Further information on the Company
can be found on its website at www.onehealth.co.uk.
This announcement should be read in
its entirety. In particular, the information in the "Important Notices" section of the
announcement should be read and understood.
About One Health Group plc
One Health engages over 70 NHS
Consultants (excluding anaesthetists) who sub-specialise in
the various surgeries offered by the Company, through a growing
network of community-based outreach clinics and surgical operating
locations. One Health continues to deliver strong growth and in the
year to March 2024 provided much needed care to 13,266 new
patients, through almost 34,000 consultations and over 6,000
surgical procedures. One Health deploys surgeons and anaesthetists
that are mostly employed by the NHS, on a subcontracted basis. It
currently works with over 100 professionals across 9 independent
hospitals and 37 outreach clinics. Within these community-based
outreach clinics all consultations and post operative physiotherapy
is delivered where required, reducing patient inconvenience and
excess travel.
One Health's activities are focused
on areas where NHS patient needs are under-supplied by the local
NHS service, population density is relatively high and the level of
private medical insurance or the ability to self-fund is relatively
low. One Health has also sought to expand geographically from its
Head Office in Sheffield into neighbouring counties which meet
these criteria. Currently, the Company's activities are focused in
Yorkshire, Lincolnshire, Derbyshire, Nottinghamshire and
Leicestershire. Revenue of over £23 million in the year to 31 March
2024 was derived from over 60 NHS commissioning bodies in addition
to contracts with local NHS Hospital Trusts to transfer their
internal waiting list patients to One Health for quicker
treatment.
One Health's business model has
focused to date on four main areas: orthopaedics, spine, general
surgery and gynaecology. The split of inpatient procedures in the
year to 31 March 2024 was as follows: orthopaedics 46% spine 22%
general surgery 22% gynaecology 10%.
Spine and orthopaedics are
particularly attractive areas for One Health as the Directors
believe that they benefit from powerful growth drivers in terms of
an ageing demographic, physical inactivity and an increasing
proportion of the population being categorised as obese. Within
orthopaedics, the most common surgeries performed by One Health are
knee and hip replacements.
*(https://www.onehealth.co.uk/investors)
The Directors of One Health Group
plc accept responsibility for the contents of this
announcement
Notification and public disclosure of transactions by persons
discharging managerial responsibilities and persons closely
associated with them.
|
1.
|
Details of the person discharging managerial
responsibilities/person closely associated
|
|
a)
|
Name:
|
Shantanu Shahane
|
|
2.
|
Reason for the notification
|
|
a)
|
Position/status:
|
Chief Medical Officer
|
|
b
|
Initial
notification/Amendment:
|
Initial notification
|
|
3.
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
|
|
a)
|
Name:
|
One Health Group plc
|
|
b)
|
LEI:
|
984500DC689F5BAD8732
|
|
4.
|
Details of the transaction(s): section to be repeated for (i)
each type of instrument; (ii) each type of transaction; (iii) each
date; and (iv) each place where transactions have been
conducted
|
|
a)
|
Description of the financial
instrument, type of instrument:
Identification code:
|
Ordinary shares of £0.005 each
ISIN Code: GB00BNNT0595
|
|
b)
|
Nature of the
transaction:
|
Sale of shares
|
|
c)
|
Price(s) and Volume (s):
|
Sale price(s). Nil
Volume(s): 35,000
|
|
d)
|
Aggregated Information:
Aggregated volume:
Price:
|
N/A
|
|
e)
|
Date of the transaction:
|
10 March 2025
|
|
f)
|
Place of the transaction
|
Aquis (AQSE)
|
|
1.
|
Details of the person discharging managerial
responsibilities/person closely associated
|
|
a)
|
Name:
|
Angela Shahane
|
|
2.
|
Reason for the notification
|
|
a)
|
Position/status:
|
Person closely associated with
Shantanu Shahane, Chief Medical Officer
|
|
b
|
Initial
notification/Amendment:
|
Initial notification
|
|
3.
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
|
|
a)
|
Name:
|
One Health Group plc
|
|
b)
|
LEI:
|
984500DC689F5BAD8732
|
|
4.
|
Details of the transaction(s): section to be repeated for (i)
each type of instrument; (ii) each type of transaction; (iii) each
date; and (iv) each place where transactions have been
conducted
|
|
a)
|
Description of the financial
instrument, type of instrument:
Identification code:
|
Ordinary shares of £0.005 each
ISIN Code: GB00BNNT0595
|
|
b)
|
Nature of the
transaction:
|
Purchase of shares
|
|
c)
|
Price(s) and Volume (s):
|
Purchase price(s). Nil
Volume(s): 35,000
|
|
d)
|
Aggregated Information:
Aggregated volume:
Price:
|
N/A
|
|
e)
|
Date of the transaction:
|
10 March 2025
|
|
f)
|
Place of the transaction
|
Aquis (AQSE)
|
|
1.
|
Details of the person discharging managerial
responsibilities/person closely associated
|
|
a)
|
Name:
|
Derek Bickerstaff
|
|
2.
|
Reason for the notification
|
|
a)
|
Position/status:
|
Non-Executive Chairman
|
|
b
|
Initial
notification/Amendment:
|
Initial notification
|
|
3.
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
|
|
a)
|
Name:
|
One Health Group plc
|
|
b)
|
LEI:
|
984500DC689F5BAD8732
|
|
4.
|
Details of the transaction(s): section to be repeated for (i)
each type of instrument; (ii) each type of transaction; (iii) each
date; and (iv) each place where transactions have been
conducted
|
|
a)
|
Description of the financial
instrument, type of instrument:
Identification code:
|
Ordinary shares of £0.005 each
ISIN Code: GB00BNNT0595
|
|
b)
|
Nature of the
transaction:
|
Sale of shares
|
|
c)
|
Price(s) and Volume (s):
|
Sale price(s). Nil
Volume(s): 1,100,000
|
|
d)
|
Aggregated Information:
Aggregated volume:
Price:
|
N/A
|
|
e)
|
Date of the transaction:
|
10 March 2025
|
|
f)
|
Place of the transaction
|
Aquis (AQSE)
|
|
1.
|
Details of the person discharging managerial
responsibilities/person closely associated
|
|
a)
|
Name:
|
Michelle Bickerstaff
|
|
2.
|
Reason for the notification
|
|
a)
|
Position/status:
|
Person closely associated with Derek
Bickerstaff, Non-Executive Chairman
|
|
b
|
Initial
notification/Amendment:
|
Initial notification
|
|
3.
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
|
|
a)
|
Name:
|
One Health Group plc
|
|
b)
|
LEI:
|
984500DC689F5BAD8732
|
|
4.
|
Details of the transaction(s): section to be repeated for (i)
each type of instrument; (ii) each type of transaction; (iii) each
date; and (iv) each place where transactions have been
conducted
|
|
a)
|
Description of the financial
instrument, type of instrument:
Identification code:
|
Ordinary shares of £0.005 each
ISIN Code: GB00BNNT0595
|
|
b)
|
Nature of the
transaction:
|
Purchase of shares
|
|
c)
|
Price(s) and Volume (s):
|
Purchase price(s). Nil
Volume(s): 1,100,000
|
|
d)
|
Aggregated Information:
Aggregated volume:
Price:
|
N/A
|
|
e)
|
Date of the transaction:
|
10 March 2025
|
|
f)
|
Place of the transaction
|
Aquis (AQSE)
|
